HIV/AIDS surveillance in Europe 2018 - 2017 data
This report is the latest in a series published jointly by European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
HIV transmission remains a major public health concern and affects more than 2 million people in the WHO European Region, particularly in the eastern part of the Region. This report finds that while epidemic patterns and trends vary widely across European countries, nearly 160 000 people were diagnosed with HIV in the European Region in 2017, including 25 000 in the EU/EEA. The increasing trend in new HIV diagnoses continued for the Region overall, despite decreasing rates of new diagnoses in the EU/EEA. The report calls for urgent action for countries and areas (especially in the eastern part) to revamp their political commitment and scale up efforts to implement the Action plan for the health sector response to HIV in the WHO European Region.
Infographic: HIV late Diagnosis - 2017 data
In the EU/EEA, almost every second HIV diagnosis happened at a late stage in 2017. This means diagnosis several years after infection.
In 2007, 49 % of those with a CD4 cell count reported at HIV diagnosis were diagnosed late (several years after infection).
Infographic: HIV and AIDS in Europe 2017
Europe experiences a persistent HIV epidemic, with only little changes in notifications during the last decade in the EU/EEA. One reason for this: an estimated 120 000 Europeans are living with undiagnosed HIV in the EU/EEA, which means that about 1 in 7 of those living with HIV are not aware of their status. And it takes on average three years from HIV infection to diagnosis.
New HIV diagnoses at alarmingly high levels in the European Region despite progress in EU/EEA
28 Nov 2018 - With nearly 160 000 people newly diagnosed with HIV, 2017 marked another year of alarming numbers of new HIV diagnoses in the WHO European Region. In contrast, the European Union and European Economic Area (EU/EEA) countries reported a decline in rates of new diagnoses, mainly driven by a 20% decrease since 2015 among men who have sex with men.
World AIDS Day 2018: Know the epidemic, shape the response
1 Dec 2018 to 1 Dec 2018 - The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.
All updates on HIV/AIDS
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
HIV and migrants: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report)
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
Reorienting health systems to care for people with HIV beyond viral suppression
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
23 Nov 2018 - This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
The benefits of HIV treatment: undetectable means you do not pass on the virus
25 Jul 2018 - Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Public health guidance on prevention and control of blood-borne viruses in prison settings
23 Jul 2018 - This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.